RADeep (Rare Anaemia Disorders European Epidemiological Platform) is a GDPR-compliant patient registry launched in 2017. It centralizes data from referral centres across multiple countries, including national and local registries, to support research, surveillance, and treatment access for rare anaemias in Europe. It enables standardized, cross-border clinical data sharing.
RADeep is endorsed by the European Rare Blood Disorders Platform (ENROL), the official registry framework of the European Reference Network on rare hematological diseases (ERN-EuroBloodNet), and by the European Haematology Association (EHA).
Company Details
- Founded
- -
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- https://www.radeepnetwork.eu/
- Competitors
- Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Vivatis Pharma Italia s.r.l., Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de Recerca, ERN-EuroBloodNet (European Reference Network on Rare Hematological Diseases), Presidenza del Consiglio dei Ministri, EURORDIS-Rare Diseases Europe, GenoMed4All, Humanitas Research Hospital, SYNTHEMA.
Radeep Network Questions
Radeep Network's website is https://www.radeepnetwork.eu/
Radeep Network's LinkedIn profile is https://www.linkedin.com/company/radeep-network
Radeep Network's industry is
Hospitals and Health Care
Radeep Network's top competitors are
Fondazione Irccs Istituto Nazionale Dei Tumori Di Milano,
Vivatis Pharma Italia S.r.l.,
Vall D’hebron Institute Of Research (Vhir) - Vall D'hebron Institut De Recerca,
Ern-Eurobloodnet (European Reference Network On Rare Hematological Diseases),
Presidenza Del Consiglio Dei Ministri,
Eurordis-Rare Diseases Europe,
Genomed4all,
Humanitas Research Hospital,
Synthema.
Radeep Network's categories are Hospitals and Health Care
Radeep Network's founding year is 2017
